Baxter International Inc. (BAX)
NYSE
Closed
Aug 24, 2026
Day's Range
26.0752 wk Range
15.73Overview - BAX - Baxter International Inc.
Key Statistics
Valuation
Enterprise Value
21.10B
P/E (Trailing)
‪86.30‬
P/E (Forward)
‪12.93‬
PEG Ratio
‪2.58‬
Price / Sales (TTM)
‪1.18‬
Price / Book
‪2.19‬
EV / EBITDA
‪11.20‬
Profitability
Gross Margin
‪34.86%‬
Profit Margin
‪-9.26%‬
Operating Margin
‪14.42%‬
Return on Assets
‪2.84%‬
Return on Equity
‪-14.37%‬
Ownership
Shares Outstanding
516.99M
Float
514.51M
Short % of Shares Outstanding
‪9.97%‬
Held by Insiders
‪0.34%‬
Held by Institutions
‪110.15%‬
Price stats
Beta
‪0.59‬
50-Day Avg
‪23.60‬
200-Day Avg
‪19.95‬
Dividends
Payout Ratio
‪307.69%‬
Frequency
Quarterly
Analyst Consensus
13 analysts
Average price target
‪$ 28.73‬Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - BAX - Baxter International Inc.
Peers - BAX - Baxter International Inc.
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on NYSE.
- BAXNYSEBaxter International Inc.13.61BMarket Cap+6.76%52-week change86.31P/E (Trailing)‪-9.26%‬Profit Margin
- BDXNYSEBecton, Dickinson and Company52.29BMarket Cap+20.40%52-week change33.22P/E (Trailing)‪4.19%‬Profit Margin
- ELNYSEThe Estée Lauder Companies Inc. Class A36.88BMarket Cap+13.86%52-week change203.88P/E (Trailing)‪1.20%‬Profit Margin
- ALCNYSEAlcon Inc.35.59BMarket Cap-9.68%52-week change56.21P/E (Trailing)‪5.92%‬Profit Margin
- RMDNYSEResMed Inc.33.39BMarket Cap-23.45%52-week change22.18P/E (Trailing)‪26.94%‬Profit Margin
- WSTNYSEWest Pharmaceutical Services, Inc.24.84BMarket Cap+29.98%52-week change45.27P/E (Trailing)‪16.98%‬Profit Margin
- SOLVNYSESolventum Corporation15.24BMarket Cap+18.78%52-week change10.95P/E (Trailing)‪17.25%‬Profit Margin
Profile Summary - BAX - Baxter International Inc.
About
Baxter International Inc. is a multinational healthcare company headquartered in Deerfield, Illinois, founded in 1931. It provides a broad portfolio of essential medical products and therapies focused on treating chronic and acute conditions in hospital and renal care settings. The company operates through key…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
